InvestorsHub Logo
Followers 16
Posts 84
Boards Moderated 0
Alias Born 05/28/2020

Re: LongTkt post# 11165

Wednesday, 07/22/2020 11:40:46 AM

Wednesday, July 22, 2020 11:40:46 AM

Post# of 42892
iHub Schedule Slip

Looks like our mutually agreed schedule has slipped for HGEN

I still think NASDAQ listing is going to happen soon - between 7/24 and 8/7. I don't think it will affect the stock price much. HGEN is already is owned by institutional investors and insiders.


The Phase 3 does not appear to have stopped early from the interim analysis, otherwise the trial enrollment status would have changed by now. That would put the trial enrollment completion to the end of August, 4 weeks to analyze/submit results to FDA, and 2 weeks (minimum) for a emergency use authorization.

Clinical Trial Site Update based on Internet searching:

Active:
-------
Phoenix, Arizona (Mayo Clinic)
Jacksonville, Florida (Mayo Clinic)
Rochester, Minnesota (Mayo Clinic)
Lebanon, New Hampshire (Dartmouth-Hitchcok)
Charlotte, North Carolina (Atrium Health)


Semi-Active:
------------
14 competing therapeutic COVID Clinical Trials ongoing
Atlanta, Georgia (Emory University)


Does Not Appear Active:
-----------------------
No mention of Lenzilumab regarding either of these hospital site.
Dallas, Texas (Texas Health)
Orlando Florida (AdventHealth)